Chromosome Disorders  >>  Bosulif (bosutinib)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Bosulif (bosutinib) / Pfizer
B1871006, NCT00261846 / 2005-004230-40: Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias

Completed
2
571
US, Canada, Europe, RoW
Bosutinib, SKI-606
Pfizer
Chronic Myeloid Leukemia
09/09
08/15
NCT00811070: Study Evaluating SKI-606 (Bosutinib) In Japanese Subjects With Philadelphia Chromosome Positive Leukemias

Completed
2
63
Japan
SKI-606 (Bosutinib)
Pfizer
Chronic Myelogenous Leukemia
03/13
06/15

Download Options